NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



Research from Fudan University in the area of tuberculosis published



March 11th, 2008

"In an effort to identify the new resistance factors in rifampin resistant: (RIFT) Mycobacterium tuberculosis (M. tb), comparative proteome analysis and gene mutation assays were used to identify the differentially expressed proteins and correlated gene mutations among clinical RIFr isolates lacking rpoB mutations, RIF sensitive (RIFs) isolates, and the laboratory H37Rv strain. MALDI-TOF-MS revealed nine differentially expressed protein spots," scientists in Shanghai, People's Republic of China report.

"PCR sequencing results showed four genes were mutated. The newly identified 191A/C mutation, in the gene Rv2629, was carried by 111 out of 112 clinical RIFr isolates....


Source: TB & Outbreaks Week (2008-03-11)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login